Andrea Cox

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	14870	5175
h-endeksi	51	39
i10-endeksi	126	102

1300

650

325

975

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202541 188 266 318 335 268 245 203 209 206 175 191 197 220 226 243 271 257 281 335 418 472 582 635 679 640 743 740 728 1022 1257 1029 979 142

Genel erişim

Tümünü görüntüle

149 makale

5 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Stuart C. Ray, M.D.Professor of Medicine and Oncology, Johns Hopkins University School of Medicinejhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Kimberly PageUniversity of New Mexico Health Sciences Centersalud.unm.edu üzerinde doğrulanmış e-posta adresine sahip
Justin BaileyJohns Hopkins Universityjhu.edu üzerinde doğrulanmış e-posta adresine sahip
Jason GrebelyProfessor, The Kirby Institute, UNSW Sydneykirby.unsw.edu.au üzerinde doğrulanmış e-posta adresine sahip
Gregory DoreUNSW Sydneykirby.unsw.edu.au üzerinde doğrulanmış e-posta adresine sahip
Andrew H. KarabaJohns Hopkinsjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Georg LauerMassachusetts General Hospital/Harvard Medical Schoolmgh.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Lisa MaherUniversity of New South Waleskirby.unsw.edu.au üzerinde doğrulanmış e-posta adresine sahip
Robert HendersonAmgen, Incamgen.com üzerinde doğrulanmış e-posta adresine sahip
Meghan MorrisAssociate Professor of Epidemiology, University of California, San Franciscoucsf.edu üzerinde doğrulanmış e-posta adresine sahip
Naglaa H. ShoukryProfessor of Medicine, Université de Montréal and Centre de Recherche du CHUM (CRCHUM)umontreal.ca üzerinde doğrulanmış e-posta adresine sahip
Andrew PardollJohns Hopkins University school of medicinejhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Shruti H MehtaJohns Hopkins Bloomberg School of Public Healthjhu.edu üzerinde doğrulanmış e-posta adresine sahip
Michael A. ChattergoonJohns Hopkins University School of Medicinejhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Kazuyasu SakaguchiHokkaido University, Faculty of Science, Department of Chemistrysci.hokudai.ac.jp üzerinde doğrulanmış e-posta adresine sahip
Alessandro Setteliai.org üzerinde doğrulanmış e-posta adresine sahip
janke schinkelAcademic Medical Center, Department of Microbiologyamc.uva.nl üzerinde doğrulanmış e-posta adresine sahip
Rachel Sacks-DavisBurnet Instituteburnet.edu.au üzerinde doğrulanmış e-posta adresine sahip
Andrew PekoszProfessor of Molecular Microbiology, Johns Hopkins Bloomberg School of Public Healthjhsph.edu üzerinde doğrulanmış e-posta adresine sahip
Behzad HajarizadehViral Hepatitis Clinical Research Program, The Kirby Institute, The University of New South Waleskirby.unsw.edu.au üzerinde doğrulanmış e-posta adresine sahip

Takip et

Andrea Cox

Professor of Medicine, Johns Hopkins University

jhmi.edu üzerinde doğrulanmış e-posta adresine sahip

Infectious diseases immunology viruses hepatitis viruses HIV


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Characterization of peptides bound to the class I MHC molecule HLA-A2. 1 by mass spectrometry DF Hunt, RA Henderson, J Shabanowitz, K Sakaguchi, H Michel, N Sevilir, ... Science 255 (5049), 1261-1263, 1992	1677	1992
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines AL Cox, J Skipper, Y Chen, RA Henderson, TL Darrow, J Shabanowitz, ... Science 264 (5159), 716-719, 1994	1155	1994
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad DF Hunt, H Michel, TA Dickinson, J Shabanowitz, AL Cox, K Sakaguchi, ... Science 256 (5065), 1817-1820, 1992	876	1992
Protection against persistence of hepatitis C SH Mehta, A Cox, DR Hoover, XH Wang, Q Mao, S Ray, SA Strathdee, ... The Lancet 359 (9316), 1478-1483, 2002	576	2002
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection J Grebely, K Page, R Sacks‐Davis, MS van der Loeff, TM Rice, J Bruneau, ... Hepatology 59 (1), 109-120, 2014	515	2014
Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection WO Osburn, BE Fisher, KA Dowd, G Urban, L Liu, SC Ray, DL Thomas, ... Gastroenterology 138 (1), 315-324, 2010	428	2010
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune … DT Le, DG Brockstedt, R Nir-Paz, J Hampl, S Mathur, J Nemunaitis, ... Clinical cancer research 18 (3), 858-868, 2012	402	2012
Cellular immune selection with hepatitis C virus persistence in humans AL Cox, T Mosbruger, Q Mao, Z Liu, XH Wang, HC Yang, J Sidney, ... The Journal of experimental medicine 201 (11), 1741-1752, 2005	379	2005
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C A Balagopal, FH Philp, J Astemborski, TM Block, A Mehta, R Long, ... Gastroenterology 135 (1), 226-233, 2008	351	2008
Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C AL Cox, T Mosbruger, GM Lauer, D Pardoll, DL Thomas, SC Ray Hepatology 42 (1), 104-112, 2005	319	2005
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection AL Cox, DM Netski, T Mosbruger, SG Sherman, S Strathdee, D Ompad, ... Clinical infectious diseases 40 (7), 951-958, 2005	317	2005
Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses WO Osburn, AE Snider, BL Wells, R Latanich, JR Bailey, DL Thomas, ... Hepatology 59 (6), 2140-2151, 2014	299	2014
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine J Grebely, M Prins, M Hellard, AL Cox, WO Osburn, G Lauer, K Page, ... The Lancet infectious diseases 12 (5), 408-414, 2012	278	2012
Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus KA Dowd, DM Netski, XH Wang, AL Cox, SC Ray Gastroenterology 136 (7), 2377-2386, 2009	276	2009
Approaches, progress, and challenges to hepatitis C vaccine development JR Bailey, E Barnes, AL Cox Gastroenterology 156 (2), 418-430, 2019	265	2019
TGFβ1-mediated SMAD3 enhances PD-1 expression on antigen-specific T cells in cancer BV Park, ZT Freeman, A Ghasemzadeh, MA Chattergoon, ... Cancer discovery 6 (12), 1366-1381, 2016	261	2016
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ... Annals of internal medicine 158 (4), 235-245, 2013	256	2013
Humoral immune response in acute hepatitis C virus infection DM Netski, T Mosbruger, E Depla, G Maertens, SC Ray, RG Hamilton, ... Clinical infectious diseases 41 (5), 667-675, 2005	244	2005
Progress towards elimination goals for viral hepatitis AL Cox, MH El-Sayed, JH Kao, JV Lazarus, M Lemoine, AS Lok, F Zoulim Nature reviews Gastroenterology & hepatology 17 (9), 533-542, 2020	196	2020
HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon MA Chattergoon, R Latanich, J Quinn, ME Winter, RW Buckheit 3rd, ... PLoS pathogens 10 (5), e1004082, 2014	196	2014

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar